DocGo Enters Material Definitive Agreement on Jan 30

Ticker: DCGO · Form: 8-K · Filed: Jan 31, 2024 · CIK: 1822359

Docgo INC. 8-K Filing Summary
FieldDetail
CompanyDocgo INC. (DCGO)
Form Type8-K
Filed DateJan 31, 2024
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.0001, $40 million, $36 million
Sentimentbullish

Complexity: simple

Sentiment: bullish

Topics: material-agreement, corporate-action, contract

TL;DR

**DocGo just signed a big deal, could be a game-changer for future growth.**

AI Summary

DocGo Inc. filed an 8-K on January 31, 2024, reporting an event on January 30, 2024, related to an "Entry into a Material Definitive Agreement." This filing indicates a significant new contract or partnership for DocGo, which could impact its future revenue and operational scope. For investors, this matters because material agreements often signal growth opportunities or strategic shifts that can influence the stock's performance, potentially leading to increased revenue or market expansion for DocGo.

Why It Matters

This filing signals a potentially significant new business opportunity or partnership for DocGo Inc., which could drive future revenue growth and expand its market presence.

Risk Assessment

Risk Level: low — The filing indicates a new material agreement, which is generally a positive development, though specific terms are not yet disclosed.

Analyst Insight

A smart investor would monitor DocGo Inc. closely for further announcements regarding the specifics of this material definitive agreement, as it could significantly impact future revenue and stock valuation.

Key Players & Entities

Forward-Looking Statements

FAQ

What was the specific event reported by DocGo Inc. in this 8-K filing?

DocGo Inc. reported an "Entry into a Material Definitive Agreement" as the earliest event on January 30, 2024, according to the filing.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on January 31, 2024, as indicated by the 'FILED AS OF DATE' and 'DATE AS OF CHANGE' in the filing header.

What is the trading symbol for DocGo Inc. common stock?

The trading symbol for DocGo Inc. common stock is DCGO, and it is registered on The Nasdaq Stock Market LLC, as stated in the 'Securities registered pursuant to Section 12(b) of the Act' section.

What is DocGo Inc.'s state of incorporation and business address?

DocGo Inc. is incorporated in Delaware, and its business address is 35 West 35th Street, Floor 6, New York, New York 10001, according to the 'COMPANY DATA' and 'BUSINESS ADDRESS' sections.

Under which SEC Act was this current report filed?

This current report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, as stated on the FORM 8-K cover page.

Filing Stats: 861 words · 3 min read · ~3 pages · Grade level 11.7 · Accepted 2024-01-31 07:41:22

Key Financial Figures

Filing Documents

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. On January 30, 2024, DocGo Inc. (the "Company") entered into an amendment (the "Amendment") to the credit agreement, dated as of November 1, 2022, by and among the Company, Citibank, N.A. as administrative agent, and the other parties thereto. The Amendment provides that, subject to certain conditions, the Company may repurchase shares of its common stock under a share repurchase program that is substantially similar to the Company's share repurchase program that expired on November 24, 2023 (the "Prior Program") (or any renewals or extensions of the Prior Program or replacement plan, as applicable) in an amount not to exceed, together with the Company's repurchases under the Prior Program, an aggregate of $40 million. The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by the full text of the Amendment, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K (this "Current Report") and incorporated by reference herein.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 31, 2024, the Company issued a press release (the "Press Release") announcing that the Company's Board of Directors has approved a new share repurchase program pursuant to which the Company may purchase up to $36 million in shares of the Company's common stock during a six-month period ending July 30, 2024 (the "Repurchase Program"). Under the terms of the Repurchase Program, the Company may purchase shares of its common stock on a discretionary basis from time to time through open market repurchases or privately negotiated transactions or through other means, including by entering into Rule 10b5-1 trading plans or accelerated share repurchase programs, in each case, during an "open window" and when the Company does not possess material non-public information. The timing and actual number of shares repurchased under the Repurchase Program will depend on a variety of factors, including stock price, trading volume, market conditions, corporate and regulatory requirements and other general business considerations. The Repurchase Program may be modified, suspended or discontinued at any time without prior notice. Repurchases under the Repurchase Program may be funded from the Company's existing cash and cash equivalents, future cash flow or proceeds of borrowings or debt offerings. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report. The information in Item 7.01 of this Current Report and the Press Release is being furnished and shall not be deemed "filed" for purposes of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 First Amendment to Credit Agreement, dated January 30, 2024, by and between the Company and Citibank, N.A., as administrative agent. 99.1 Press Release dated January 31 , 202 4 . 104 Cover Page Interactive Data File (formatted as Inline XBRL). 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DOCGO INC. By: /s/ Norman Rosenberg Name: Norman Rosenberg Title: Chief Financial Officer and Treasurer Date: January 31, 2024 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing